FDA Approved: PIASKY — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

FDA approved a supplemental application for PIASKY (crovalimab) from Genentech, Inc., resulting in an updated labeling per the approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• PIASKY (crovalimab)

Snippet

SUPPL AP for PIASKY (CROVALIMAB)